User Fee Waivers for FDC and Co-Packaged HIV Drugs for PEPFAR
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
February 8, 2007
May 5, 2020
13c7af5f-84b1-4023-80d0-9ff6cb3357dc
Related Documents
Role of HIV Drug Resistance Testing in Antiretroviral Drug Development
Guidance DocumentOctober 31, 2007Center for Drug Evaluation and Research
Nonclinical Safety Evaluation of Pediatric Drug Products
Guidance DocumentFebruary 15, 2006Center for Drug Evaluation and Research
Prescription Drug Marketing Act — Donation of Prescription Drug Samples to Free Clinics
Guidance DocumentMarch 14, 2006Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox